Core Scientific’s (CORZ) “Buy” Rating Reiterated at BTIG Research

BTIG Research reaffirmed their buy rating on shares of Core Scientific (NASDAQ:CORZ) in a research report report published on Thursday,Benzinga reports. They currently have a $38.00 price target on the stock.

CORZ has been the subject of a number of other research reports. B. Riley Financial upped their price objective on shares of Core Scientific from $33.00 to $42.00 and gave the company a “buy” rating in a research note on Monday, August 3rd. Rothschild & Co Redburn initiated coverage on shares of Core Scientific in a report on Monday, September 21st. They set a “neutral” rating and a $16.00 target price on the stock. Freedom Capital upgraded shares of Core Scientific from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. Canaccord Genuity Group lifted their target price on shares of Core Scientific from $30.00 to $36.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Finally, Capital One Financial set a $33.00 price target on shares of Core Scientific in a research note on Thursday, July 30th. Two research analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $31.36.

Core Scientific Price Performance

Shares of CORZ opened at $13.48 on Thursday. The firm has a market cap of $4.33 billion, a P/E ratio of -3.05 and a beta of 5.49. The stock has a 50 day simple moving average of $17.30 and a two-hundred day simple moving average of $20.99. Core Scientific has a 1 year low of $12.31 and a 1 year high of $30.46.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings results on Tuesday, July 28th. The company reported ($3.32) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The business had revenue of $164.20 million for the quarter, compared to analyst estimates of $144.83 million. On average, equities analysts anticipate that Core Scientific will post -1.36 earnings per share for the current year.

Insider Transactions at Core Scientific

In other Core Scientific news, insider Todd DuChene sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $19.97, for a total transaction of $199,700.00. Following the completion of the transaction, the insider owned 1,969,101 shares of the company’s stock, valued at $39,322,946.97. This represents a 0.51% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last quarter, insiders bought 19,000 shares of company stock worth $342,290 and sold 100,000 shares worth $1,881,300. 1.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Core Scientific

Large investors have recently made changes to their positions in the business. Handelsbanken Fonder AB raised its holdings in shares of Core Scientific by 0.7% during the second quarter. Handelsbanken Fonder AB now owns 94,500 shares of the company’s stock valued at $2,418,000 after acquiring an additional 700 shares in the last quarter. GAMMA Investing LLC lifted its stake in Core Scientific by 34.5% in the second quarter. GAMMA Investing LLC now owns 3,049 shares of the company’s stock worth $78,000 after acquiring an additional 782 shares during the period. Parkside Financial Bank & Trust lifted its stake in Core Scientific by 1,371.3% in the second quarter. Parkside Financial Bank & Trust now owns 1,177 shares of the company’s stock worth $30,000 after acquiring an additional 1,097 shares during the period. Carronade Capital Management LP lifted its stake in Core Scientific by 1.1% in the first quarter. Carronade Capital Management LP now owns 101,103 shares of the company’s stock worth $1,513,000 after acquiring an additional 1,103 shares during the period. Finally, Counterpoint Mutual Funds LLC boosted its holdings in Core Scientific by 9.3% in the third quarter. Counterpoint Mutual Funds LLC now owns 14,425 shares of the company’s stock valued at $231,000 after acquiring an additional 1,224 shares in the last quarter.

Key Headlines Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analyst support remains strong. Cantor Fitzgerald reaffirmed its “Overweight” rating, while Canaccord Genuity and BTIG Research reiterated “Buy” ratings with price targets of $36 and $38, respectively. The broader analyst consensus remains “Moderate Buy,” with an average target of $31.36. Cantor Fitzgerald Reaffirms Overweight Rating for Core Scientific
• Positive Sentiment: Core Scientific’s scheduled third-quarter earnings release on November 5 gives investors a near-term catalyst. Results and management commentary should provide updates on its high-density colocation and artificial-intelligence data-center expansion. Core Scientific Schedules Third Quarter Earnings Release
• Neutral Sentiment: A recent rebound occurred on above-average volume, but Zacks cautioned that current earnings-estimate revisions may not support additional near-term gains. This suggests momentum traders may remain cautious despite the strong analyst targets. Strength Seen in Core Scientific
• Negative Sentiment: Investor risk appetite has weakened for leveraged AI-data-center developers, pressuring Core Scientific alongside Applied Digital and TeraWulf. Concerns about financing costs, valuation, and tenant credit quality—including pressure facing customer CoreWeave—could weigh on the shares. Rotation Out of Debt-Funded AI Builders
• Negative Sentiment: Insider Todd Duchene sold 10,000 shares for approximately $151,200, reducing his position by 0.85%. While the remaining stake is substantial, the transaction adds a modest negative signal. Core Scientific Insider Selling

Core Scientific Company Profile

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.